Outlook Therapeutics
OTLK
OTLK
64 hedge funds and large institutions have $9.5M invested in Outlook Therapeutics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
24% less call options, than puts
Call options by funds: $31K | Put options by funds: $41K
Holders
64
Holding in Top 10
–
Calls
$31K
Puts
$41K
Top Buyers
| 1 | +$663K | |
| 2 | +$618K | |
| 3 | +$542K | |
| 4 |
Squarepoint
New York
|
+$249K |
| 5 |
Renaissance Technologies
New York
|
+$170K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$1.05M | |
| 3 | -$488K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$324K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$301K |
